Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1394

1.

Systematic review: chronic viral hepatitis and metabolic derangement.

Wang CC, Cheng PN, Kao JH.

Aliment Pharmacol Ther. 2019 Nov 20. doi: 10.1111/apt.15575. [Epub ahead of print] Review.

PMID:
31746482
2.

Hepatobiliary and Pancreatic: Biliary hamartoma manifests as liver cysts.

Lin HH, Liao SH, Huang YL, Liu KL, Kao JH.

J Gastroenterol Hepatol. 2019 Nov 11. doi: 10.1111/jgh.14821. [Epub ahead of print] Review. No abstract available.

PMID:
31711267
3.

Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: real-world effectiveness and safety in Taiwan.

Liu CH, Liu CJ, Hung CC, Hsieh SM, Su TH, Sun HY, Tseng TC, Chen PJ, Chen DS, Kao JH.

Liver Int. 2019 Nov 11. doi: 10.1111/liv.14295. [Epub ahead of print]

PMID:
31710759
4.

Dietary L-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gut.

Kitamoto S, Alteri CJ, Rodrigues M, Nagao-Kitamoto H, Sugihara K, Himpsl SD, Bazzi M, Miyoshi M, Nishioka T, Hayashi A, Morhardt TL, Kuffa P, Grasberger H, El-Zaatari M, Bishu S, Ishii C, Hirayama A, Eaton KA, Dogan B, Simpson KW, Inohara N, Mobley HLT, Kao JY, Fukuda S, Barnich N, Kamada N.

Nat Microbiol. 2019 Nov 4. doi: 10.1038/s41564-019-0591-6. [Epub ahead of print]

PMID:
31686025
5.

Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patients.

Hsu SJ, Enkhzaya S, Lin YY, Tseng TC, Khosbayar T, Tsai CH, Wang TS, Enkhtuya D, Ivshinkhorol D, Naranzul N, Jargalsaikhan B, Amarsanaa J, Baatarkhuu O, Kao JH.

J Formos Med Assoc. 2019 Oct 28. pii: S0929-6646(19)30819-8. doi: 10.1016/j.jfma.2019.10.003. [Epub ahead of print]

6.

Transient Subgranular Hyperconnectivity to L2/3 and Enhanced Pairwise Correlations During the Critical Period in the Mouse Auditory Cortex.

Meng X, Solarana K, Bowen Z, Liu J, Nagode DA, Sheikh A, Winkowski DE, Kao JPY, Kanold PO.

Cereb Cortex. 2019 Oct 30. pii: bhz213. doi: 10.1093/cercor/bhz213. [Epub ahead of print]

PMID:
31667495
7.

Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?

Hsu SJ, Yang SS, Kao JH.

J Formos Med Assoc. 2019 Oct 16. pii: S0929-6646(19)30522-4. doi: 10.1016/j.jfma.2019.09.006. [Epub ahead of print] Review.

8.

How can individuals and the GI community reduce climate change?

Williams JA, Kao JY, Omary MB.

Gastroenterology. 2019 Oct 15. pii: S0016-5085(19)41452-2. doi: 10.1053/j.gastro.2019.10.013. [Epub ahead of print] No abstract available.

PMID:
31626756
9.

Correction: Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cells.

Ma JW, Hung CM, Lin YC, Ho CT, Kao JY, Way TD.

Oncotarget. 2019 Oct 1;10(55):5727-5729. doi: 10.18632/oncotarget.27230. eCollection 2019 Oct 1.

10.

Considerations in using recurrent neural networks to probe neural dynamics.

Kao JC.

J Neurophysiol. 2019 Oct 16. doi: 10.1152/jn.00467.2018. [Epub ahead of print]

PMID:
31619125
11.

Serum Mac-2-binding protein glycosylation isomer at virological remission predicts hepatocellular carcinoma and death in chronic hepatitis B related cirrhosis.

Su TH, Peng CY, Tseng TC, Yang HC, Liu CJ, Liu CH, Chen PJ, Chen DS, Kao JH.

J Infect Dis. 2019 Oct 1. pii: jiz496. doi: 10.1093/infdis/jiz496. [Epub ahead of print]

PMID:
31574141
12.

A new class of disordered elements controls DNA replication through initiator self-assembly.

Parker MW, Bell M, Mir M, Kao JA, Darzacq X, Botchan MR, Berger JM.

Elife. 2019 Sep 27;8. pii: e48562. doi: 10.7554/eLife.48562.

13.

EvoChromo: towards a synthesis of chromatin biology and evolution.

Drinnenberg IA, Berger F, Elsässer SJ, Andersen PR, Ausió J, Bickmore WA, Blackwell AR, Erwin DH, Gahan JM, Gaut BS, Harvey ZH, Henikoff S, Kao JY, Kurdistani SK, Lemos B, Levine MT, Luger K, Malik HS, Martín-Durán JM, Peichel CL, Renfree MB, Rutowicz K, Sarkies P, Schmitz RJ, Technau U, Thornton JW, Warnecke T, Wolfe KH.

Development. 2019 Sep 26;146(19). pii: dev178962. doi: 10.1242/dev.178962.

PMID:
31558570
14.

REAL-B (Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV) Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy.

Yang HI, Yeh ML, Wong GL, Peng CY, Chen CH, Trinh HN, Cheung KS, Xie Q, Su TH, Kozuka R, Lee DH, Ogawa E, Zhao C, Ning HB, Huang R, Li J, Zhang JQ, Ide T, Xing H, Iwane S, Takahashi H, Wong C, Wong C, Lin CH, Hoang J, le A, Henry L, Toyoda H, Ueno Y, Gane EJ, Eguchi Y, Kurosaki M, Wu C, Liu C, Shang J, Furusyo N, Enomoto M, Kao JH, Yuen MF, Yu ML, Nguyen MH.

J Infect Dis. 2019 Sep 24. pii: jiz477. doi: 10.1093/infdis/jiz477. [Epub ahead of print]

PMID:
31550363
15.

Distinct Physiological Characteristics of Isolated Laryngopharyngeal Reflux Symptoms.

Lien HC, Wang CC, Kao JY, Yeh HZ, Hsu JY, Lee SW, Chuang CY, Tsou YA, Wang JD, Vaezi MF, Chang CS.

Clin Gastroenterol Hepatol. 2019 Sep 20. pii: S1542-3565(19)31025-0. doi: 10.1016/j.cgh.2019.08.064. [Epub ahead of print]

PMID:
31546059
16.

APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation.

Kanda T, Lau GKK, Wei L, Moriyama M, Yu ML, Chuang WL, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Kadir Dokmeci A, Mamun-Al-Mahtab, McCaughan GW, Wasim J, Crawford DHG, Kao JH, Ooka Y, Yokosuka O, Sarin SK, Omata M.

Hepatol Int. 2019 Nov;13(6):649-661. doi: 10.1007/s12072-019-09988-7. Epub 2019 Sep 20.

PMID:
31541423
17.

Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop?

Kao JH, Berg T.

Gut. 2019 Dec;68(12):2105-2106. doi: 10.1136/gutjnl-2019-319648. Epub 2019 Sep 16. No abstract available.

PMID:
31527067
18.

Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism.

Su TH, Yang HC, Tseng TC, Chou SW, Lin CH, Liu CH, Liu CJ, Chen CL, Kao JH.

Mov Disord. 2019 Sep 10. doi: 10.1002/mds.27848. [Epub ahead of print]

PMID:
31505068
19.

High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.

Tseng TC, Liu CJ, Hsu CY, Hong CM, Su TH, Yang WT, Chen CL, Yang HC, Huang YT, Fang-Tzu Kuo S, Liu CH, Chen PJ, Chen DS, Kao JH.

Gastroenterology. 2019 Aug 27. pii: S0016-5085(19)41248-1. doi: 10.1053/j.gastro.2019.08.028. [Epub ahead of print]

PMID:
31470004
20.

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium.

Huang CF, Iio E, Jun DW, Ogawa E, Toyoda H, Hsu YC, Haga H, Iwane S, Enomoto M, Lee DH, Wong G, Liu CH, Tada T, Chuang WL, Cheung R, Hayashi J, Tseng CH, Yasuda S, Tran S, Kam L, Henry L, Jeong JY, Nomura H, Park SH, Nakamuta M, Huang JF, Tai CM, Lo GH, Lee MH, Yang HI, Kao JH, Tamori A, Eguchi Y, Ueno Y, Furusyo N, Tanaka Y, Yu ML, Nguyen MH; REAL-C Investigators.

Hepatol Int. 2019 Sep;13(5):587-598. doi: 10.1007/s12072-019-09974-z. Epub 2019 Aug 28.

PMID:
31463665
21.

Trouble at the junction: When myopathy and myasthenia overlap.

Nicolau S, Kao JC, Liewluck T.

Muscle Nerve. 2019 Dec;60(6):648-657. doi: 10.1002/mus.26676. Epub 2019 Sep 10. Review.

PMID:
31449669
22.

Three-dimensional modeling of human neurodegeneration: brain organoids coming of age.

Grenier K, Kao J, Diamandis P.

Mol Psychiatry. 2019 Aug 23. doi: 10.1038/s41380-019-0500-7. [Epub ahead of print] Review.

PMID:
31444473
23.

Defining Protein Pattern Differences Among Molecular Subtypes of Diffuse Gliomas Using Mass Spectrometry.

Djuric U, Lam KHB, Kao J, Batruch I, Jevtic S, Papaioannou MD, Diamandis P.

Mol Cell Proteomics. 2019 Oct;18(10):2029-2043. doi: 10.1074/mcp.RA119.001521. Epub 2019 Jul 28.

PMID:
31353322
24.

Successful treatment of nasal-type extra-nodal natural killer/T cell lymphoma with simultaneous involvement of the thyroid, liver, and pancreas.

Chang SH, Kao JH, Liang JD, Wu SJ.

Ann Hematol. 2019 Sep;98(9):2243-2246. doi: 10.1007/s00277-019-03752-5. Epub 2019 Jul 6. No abstract available.

PMID:
31280335
25.

Citronellol Induces Necroptosis of Human Lung Cancer Cells via TNF-α Pathway and Reactive Oxygen Species Accumulation.

Yu WN, Lai YJ, Ma JW, Ho CT, Hung SW, Chen YH, Chen CT, Kao JY, Way TD.

In Vivo. 2019 Jul-Aug;33(4):1193-1201. doi: 10.21873/invivo.11590.

26.

Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C.

Hsu SJ, Chiu MC, Fang YJ, Yang TH, Yu JJ, Chen CC, Kuo CC, Lee JY, Chen CH, Chen DS, Kao JH.

J Formos Med Assoc. 2019 Aug;118(8):1187-1192. doi: 10.1016/j.jfma.2019.06.014. Epub 2019 Jul 3.

27.

Antiproliferation for Breast Cancer Cells by Ethyl Acetate Extract of Nepenthes thorellii x (ventricosa x maxima).

Ou-Yang F, Tsai IH, Tang JY, Yen CY, Cheng YB, Farooqi AA, Chen SR, Yu SY, Kao JK, Chang HW.

Int J Mol Sci. 2019 Jul 1;20(13). pii: E3238. doi: 10.3390/ijms20133238.

28.

Letter: contraindicated drug-drug interactions before and after initiation of direct-acting anti-viral agents in chronic hepatitis C patients in Taiwan. Authors' reply.

Liu CH, Kao JH.

Aliment Pharmacol Ther. 2019 Jul;50(1):115-116. doi: 10.1111/apt.15329. No abstract available.

PMID:
31184389
29.

Can propranolol prevent progression of melanoma?

Kao J, Luu B.

JAAPA. 2019 Jun;32(6):1-5. doi: 10.1097/01.JAA.0000558241.84003.91.

PMID:
31136408
30.

Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota.

Hsu PI, Pan CY, Kao JY, Tsay FW, Peng NJ, Kao SS, Chen YH, Tsai TJ, Wu DC, Tsai KW.

J Gastroenterol Hepatol. 2019 May 22. doi: 10.1111/jgh.14736. [Epub ahead of print]

PMID:
31115933
31.

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease.

Shen TJ, Jhan MK, Kao JC, Ho MR, Tsai TT, Tseng PC, Wang YT, Lin CF.

J Vis Exp. 2019 Apr 28;(146). doi: 10.3791/59132.

PMID:
31081826
32.

Proteomic analysis of meningiomas reveals clinically-distinct molecular patterns.

Papaioannou MD, Djuric U, Kao J, Karimi S, Zadeh G, Aldape K, Diamandis P.

Neuro Oncol. 2019 May 11. pii: noz084. doi: 10.1093/neuonc/noz084. [Epub ahead of print]

PMID:
31077268
33.

Improved quantitative assessment of HBV-associated liver fibrosis using second-harmonic generation microscopy with feature selection.

Hsiao CY, Teng X, Su TH, Lee PH, Kao JH, Huang KW.

Clin Res Hepatol Gastroenterol. 2019 May 7. pii: S2210-7401(19)30093-2. doi: 10.1016/j.clinre.2019.04.003. [Epub ahead of print]

34.

Early Childhood Anemia in a Birth Cohort in Coastal Kenya: Links to Infection and Nutrition.

Kao J, Mutuku F, Martin S, Lee J, Mwandi J, Mukoko D, Malhotra I, King CH, LaBeaud AD.

Am J Trop Med Hyg. 2019 Jul;101(1):242-252. doi: 10.4269/ajtmh.17-0688.

35.

NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.

Su TH, Liao SH, Hong CM, Liu CJ, Tseng TC, Liu CH, Yang HC, Chen PJ, Chen DS, Chen CL, Adhoute X, Bourlière M, Kao JH.

J Gastroenterol Hepatol. 2019 May 7. doi: 10.1111/jgh.14705. [Epub ahead of print]

PMID:
31062879
36.

Citrobacter rodentium Induces Tissue-Resident Memory CD4+ T Cells.

Bishu S, Hou G, El Zaatari M, Bishu SR, Popke D, Zhang M, Grasberger H, Zou W, Stidham RW, Higgins PDR, Spence JR, Kamada N, Kao JY.

Infect Immun. 2019 Jun 20;87(7). pii: e00295-19. doi: 10.1128/IAI.00295-19. Print 2019 Jul.

PMID:
31061145
37.

Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotyping.

Kao JH, Lin CY, Chuang WL, Cheng YY, Hu JY, Liang WK, Friebe P, Palmer S, Huang CS.

Diagn Microbiol Infect Dis. 2019 Aug;94(4):344-348. doi: 10.1016/j.diagmicrobio.2019.02.020. Epub 2019 Mar 12.

PMID:
30975461
38.

Curcumin Promotes Connexin 43 Degradation and Temozolomide-Induced Apoptosis in Glioblastoma Cells.

Huang BR, Tsai CH, Chen CC, Way TD, Kao JY, Liu YS, Lin HY, Lai SW, Lu DY.

Am J Chin Med. 2019;47(3):657-674. doi: 10.1142/S0192415X19500344. Epub 2019 Apr 11.

PMID:
30974966
39.

Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.

Wei L, Pavlovic V, Bansal AT, Chen X, Foster GR, He H, Kao JH, Lampertico P, Liaw YF, Motoc A, Papatheodoridis GV, Piratvisuth T, Plesniak R, Wat C.

J Viral Hepat. 2019 Sep;26(9):1040-1049. doi: 10.1111/jvh.13107. Epub 2019 Jul 23.

PMID:
30972912
40.

An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions.

Huang CF, Hung CH, Cheng PN, Bair MJ, Huang YH, Kao JH, Hsu SJ, Lee PL, Chen JJ, Chien RN, Peng CY, Lin CY, Hsieh TY, Cheng CH, Dai CY, Huang JF, Chuang WL, Yu ML.

J Infect Dis. 2019 Jul 19;220(4):557-566. doi: 10.1093/infdis/jiz154.

PMID:
30957170
41.

Release parameters during progressive degeneration of dopamine neurons in a mouse model reveal earlier impairment of spontaneous than forced behaviors.

Chen YH, Hsieh TH, Kuo TT, Kao JH, Ma KH, Huang EY, Chou YC, Olson L, Hoffer BJ.

J Neurochem. 2019 Jul;150(1):56-73. doi: 10.1111/jnc.14702. Epub 2019 May 9.

PMID:
30933310
42.

Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis.

Liu CH, Shih YL, Yang SS, Lin CL, Fang YJ, Cheng PN, Chen CY, Peng CY, Hsieh TY, Chiu YC, Su TH, Liu CJ, Yang HC, Chen PJ, Chen DS, Kao JH.

J Gastroenterol Hepatol. 2019 Apr 1. doi: 10.1111/jgh.14672. [Epub ahead of print]

PMID:
30931537
43.

Publisher Correction: Brain-machine interface cursor position only weakly affects monkey and human motor cortical activity in the absence of arm movements.

Stavisky SD, Kao JC, Nuyujukian P, Pandarinath C, Blabe C, Ryu SI, Hochberg LR, Henderson JM, Shenoy KV.

Sci Rep. 2019 Mar 28;9(1):5528. doi: 10.1038/s41598-018-37930-8.

44.

Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done.

Hsu YC, Tseng CH, Kao JH.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):1000-1001. doi: 10.1016/j.cgh.2018.09.002. No abstract available.

PMID:
30902225
45.

Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: a systematic review and meta-analysis of individual participant data.

Pavlovic V, Yang L, Chan HL, Hou J, Janssen HL, Kao JH, Lampertico P, Peng CY, Piratvisuth T, Thompson AJ, Wedemeyer H, Wei L, Wat C.

Antivir Ther. 2019;24(2):133-140. doi: 10.3851/IMP3304.

PMID:
30865588
46.

Performance of Acoustic Radiation Force Impulse Elastography for Staging Liver Fibrosis in Patients with Chronic Hepatitis C after Viral Eradication.

Chen SH, Lai HC, Chiang IP, Su WP, Lin CH, Kao JT, Chuang PH, Hsu WF, Wang HW, Chen HY, Huang GT, Peng CY.

Clin Infect Dis. 2019 Feb 28. pii: ciz161. doi: 10.1093/cid/ciz161. [Epub ahead of print]

PMID:
30816416
47.

Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Li YT, Wu HL, Kao JH, Cheng HR, Ho MC, Wang CC, Chen PJ, Chen DS, Liu CJ.

Hepatology. 2019 Jul;70(1):184-197. doi: 10.1002/hep.30581. Epub 2019 Apr 14.

PMID:
30802976
48.

Sarcopenia and chronic liver diseases.

Hsu CS, Kao JH.

Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1229-1244. doi: 10.1080/17474124.2018.1534586. Epub 2018 Oct 16. Review.

PMID:
30791794
49.

Reply.

Kao JY, Wu DC.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1647-1648. doi: 10.1016/j.cgh.2019.02.015. Epub 2019 Feb 13. No abstract available.

PMID:
30771498
50.

IL-10 produced by macrophages regulates epithelial integrity in the small intestine.

Morhardt TL, Hayashi A, Ochi T, Quirós M, Kitamoto S, Nagao-Kitamoto H, Kuffa P, Atarashi K, Honda K, Kao JY, Nusrat A, Kamada N.

Sci Rep. 2019 Feb 4;9(1):1223. doi: 10.1038/s41598-018-38125-x.

Supplemental Content

Support Center